Search research articles
Contact Us
Filters
Showing results (181-190 of 206) with videos related to
Page
of 21
Sort By:
Molecular Cancer Therapeutics
|
August 28, 2020
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
Yoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, et al.
International Journal of Clinical Oncology
|
February 12, 2025
Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-P
Masashi Kato, Hiroyuki Sato, Yushi Naito, et al.
European Urology Oncology
|
June 16, 2019
Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer
Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, et al.
Journal of Cancer Research and Clinical Oncology
|
September 15, 2017
The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor
Akitoshi Takizawa, Koji Kawai, Takashi Kawahara, et al.
Nature Genetics
|
February 28, 2012
Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese
Shusuke Akamatsu, Ryo Takata, Christopher A Haiman, et al.
Cancer Immunology, Immunotherapy : CII
|
February 2, 2023
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial
Masaki Shiota, Hideaki Miyake, Masayuki Takahashi, et al.
Cancer Science
|
September 24, 2025
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab
Tokiyoshi Tanegashima, Masaki Shiota, Shusuke Akamatsu, et al.
International Journal of Clinical Oncology
|
July 19, 2024
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity
Hiroshi Fujiwara, Masashi Kubota, Yu Hidaka, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2024
Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study
Tomoko Kobayashi, Shintaro Iwama, Ayana Yamagami, et al.
British Journal of Cancer
|
June 7, 2024
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
Takayuki Owaki, Tadashi Iida, Yuki Miyai, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 206) with videos related to
Sort By:
Page
of 21
Molecular Cancer Therapeutics
|
August 28, 2020
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
Yoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, et al.
International Journal of Clinical Oncology
|
February 12, 2025
Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-P
Masashi Kato, Hiroyuki Sato, Yushi Naito, et al.
European Urology Oncology
|
June 16, 2019
Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer
Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, et al.
Journal of Cancer Research and Clinical Oncology
|
September 15, 2017
The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor
Akitoshi Takizawa, Koji Kawai, Takashi Kawahara, et al.
Nature Genetics
|
February 28, 2012
Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese
Shusuke Akamatsu, Ryo Takata, Christopher A Haiman, et al.
Cancer Immunology, Immunotherapy : CII
|
February 2, 2023
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial
Masaki Shiota, Hideaki Miyake, Masayuki Takahashi, et al.
Cancer Science
|
September 24, 2025
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab
Tokiyoshi Tanegashima, Masaki Shiota, Shusuke Akamatsu, et al.
International Journal of Clinical Oncology
|
July 19, 2024
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity
Hiroshi Fujiwara, Masashi Kubota, Yu Hidaka, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2024
Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study
Tomoko Kobayashi, Shintaro Iwama, Ayana Yamagami, et al.
British Journal of Cancer
|
June 7, 2024
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
Takayuki Owaki, Tadashi Iida, Yuki Miyai, et al.
Page
of 21